StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mizuho Securities Upgrades Audentes Therapeutics (BOLD) to Buy
August 8, 2018 5:03 AM
Mizuho Securities upgraded Audentes Therapeutics (NASDAQ: BOLD) from Neutral to Buy with a price target of $45.00 (from $38.00).Analyst Difei ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Upgrades